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Missed opportunitiesBackground: Missed opportunities for vaccination (MOVs) occur when persons eligible for vaccination
visit a health facility and do not get the vaccines they need. We conducted a systematic review to assess
effects of interventions for reducing MOVs.
Methods: We searched PubMed, Scopus, and the Cochrane Central Register of Controlled Trials in April
2017. Three authors independently screened search outputs, reviewed potentially eligible papers,
assessed risk of bias, and extracted data; resolving disagreements by consensus. We expressed study
results as risk ratios (RR) with 95% confidence intervals (CI) and assessed the certainty of the evidence
using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) tool.
Results: Six studies (five trials and one cohort study) met our inclusion criteria, all conducted in the
United States of America. All six studies had various limitations and were classified as having a high risk
of bias. We found moderate certainty evidence that the following interventions probably improve vacci-
nation coverage: patient education (RR 1.92, 95% CI 1.38–2.68), patient tracking using community health
workers (RR 1.18, 95% CI 1.11–1.25), and patient tracking and provider prompts (RR 1.24, 95% CI 1.18–
1.31). In addition, we found low certainty evidence that concurrent interventions targeting health-
facility (education, prompts, and audit and feedback) and family settings (phone calls) may increase vac-
cination coverage (RR 1.25, 95% CI 1.08–1.46).
Conclusions: The currently available evidence suggests that patient education, patient tracking, outreach
sessions, and provider prompts reduce missed opportunities for vaccination and improve vaccination
coverage. Rigorous studies are required to confirm these findings and increase the certainty of the current
evidence base. WHO is currently coordinating efforts to generate such evidence, especially from low-
income and middle-income countries, and it is likely that the data will be available in the next few years.
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Immunization is a proven tool for controlling life-threatening
infectious diseases, and is estimated to prevent more than three
million deaths annually [1,2]. Immunization has the potential to
do more, if missed opportunities for vaccination (MOVs) are elim-
inated and global vaccination coverage improves [3,4]. An MOV
occurs when a person who is eligible for vaccination, and has no
contraindication to vaccination, visits a healthcare service and does
not receive all the needed vaccine doses [5]. MOVs may occur dur-
ing visits for preventive or curative services [5]. Eliminating MOVs
in both settings will increase the overall immunization coverage
[6]. Surveys conducted in multiple settings show that, on average,
one-third of children who visit health facilities in low and middle-
income countries miss opportunities to receive the vaccine doses
that they need [3,5,7]. Such missed opportunities make a substan-
tial contribution to the 19.5 million children who fail to receive the
basic set of routine vaccines scheduled for their first year of life [2].
Thus, the objective of this systematic review is to assess the effects
of interventions for reducing MOVs, on vaccination coverage.
2. Materials and methods
2.1. Registration of the review
This systematic review was registered in the International
prospective register of systematic reviews (PROSPERO), with regis-
tration number CRD42017068816 [8].
2.2. Criteria for considering studies in this review
2.2.1. Types of studies
We included randomized trials (with randomization at either
individual or cluster levels) and cohort studies.
2.2.2. Types of participants
Eligible studies had to include one or more of the following
types of participants:
 individuals eligible for vaccinations;
 caregivers of individuals eligible for vaccinations; and
 healthcare workers responsible for rendering immunization
services.
2.2.3. Types of interventions and comparisons
Eligible interventions were those that led healthcare providers
to check immunization histories of people attending curative orpreventive services, in order to identify people eligible for vaccina-
tion and give them the required vaccine doses. Such interventions
could target recipients of care (e.g. educating patients to prompt
providers to check their vaccination cards), providers of care
(e.g. training, supervision, reminders, audit and feedback,
incentives), or the healthcare system (e.g. changing practices at
healthcare clinics, systematic screening of immunization histories
of individuals admitted to hospital, bringing vaccination services
closer to consultation rooms). These interventions had to be com-
pared to no intervention, standard practices in the study settings,
alternative interventions, or the same interventions implemented
at a different intensity.2.2.4. Types of outcome measures
Our outcomes were the rate of MOVs and vaccination coverage,
as defined by the authors of included studies. MOVs are a surrogate
for vaccination coverage, since a decrease in MOVs translates to an
increase in vaccination coverage. This explains why in this review
we have mostly reported vaccination coverage and not both
outcomes.2.3. Data sources
In April 2017, we searched PubMed, Scopus, and the Cochrane
Central Register of Controlled Trials (CENTRAL) with no language
or date restrictions. As shown in Appendix 1, we used combina-
tions of the following terms in the search strategy, adapted to each
database: immunization, vaccination, uptake, coverage, adhering,
adherence, and missed opportunities. In addition, we searched ref-
erence lists of included studies and related systematic reviews.
Two authors developed the search strategy, with input from the
other authors. One author conducted electronic searches and three
authors searched reference lists of relevant publications.2.4. Study selection
Three review authors independently screened the titles and
abstracts of records identified in the search output, for potentially
eligible studies. We obtained the full text publication for any study
that was considered potentially eligible by one or more of the three
authors. The three authors independently assessed the full text of
each potentially eligible study and classified it as either included
or excluded. We have provided reasons for excluding potentially
eligible studies from the review. Disagreements among the three
authors, during the screening of search outputs and study
selection, were resolved through discussion and consensus. The
A. Jaca et al. / Vaccine 36 (2018) 2921–2927 2923consensus decision of the three authors on study selection was
final, with no arbitration by another author.
2.5. Data extraction
Three review authors independently extracted data using a spe-
cially designed data extraction form. Information was extracted on
country of study, study design, participants, intervention and com-
parison, outcome measures, and results. The three authors com-
pared extracted data and resolved discrepancies through
discussion and consensus. A fourth author verified and made final
decisions on the extracted data.
2.6. Risk of bias assessment
Three authors assessed risk of bias in randomized trials using
the Cochrane Risk of Bias Tool [9]. Assessment was done using
seven domains: sequence generation, allocation concealment,
blinding of participants and personnel, blinding of outcome asses-
sors, completeness of outcome data, completeness of outcome
reporting, and other sources of bias. Each domain was recorded
as low, high, or unclear risk of bias. Overall, each randomized trial
was considered to have a low risk of bias if it scored ‘‘low risk” for
allocation concealment, blinding of outcome assessors, and com-
pleteness of outcome data. A trial was deemed to have a high risk
of bias if it recorded ‘high risk” for at least one of the three
domains. All other trials would be considered to have a moderate
risk of bias.
The risk of bias for the cohort study was evaluated using the
Risk of Bias in Non-randomized Studies of Interventions
(ROBINS-I) tool [10]. The ROBINS-I tool assesses whether there
exists bias in a study due to confounding, selection of participants
into the study, classification of interventions, deviations from
intended interventions, missing data, measurement of outcomes,
and selection of the reported result. We scored each domain as
‘‘no” if there was no risk of bias or ‘‘yes” if there was a risk of bias.
We would have considered the cohort study to have a low risk of
bias if the study scored ‘‘no” for risk of bias due to each of the fol-
lowing three domains: confounding, deviations from intended
intervention, and measurement of outcomes. We would have con-
sidered the study to have a ‘‘high risk of bias” if the study scored
‘‘yes” for risk of bias due to one or more of the three domains. If
the study did not satisfy the conditions for a ‘‘low” or ‘‘high” risk
of bias, we would have considered the study to have a moderate
risk of bias.
The three authors compared their risk of bias assessments, and
resolved discrepancies through discussion and consensus. A fourth
author verified the risk of bias assessments, and made final deci-
sions on the risk of bias in included studies.
2.7. Data synthesis
We conducted analyses using the Cochrane Review Manager
[11]. We expressed study results as risk ratios (RR) with their
95% confidence intervals (CI). We did not conduct a meta-
analysis, due to the variation in interventions among the included
studies. Two authors independently assessed the certainty of the
evidence using the Grading of Recommendations Assessment,
Development and Evaluation (GRADE) approach [12].
The GRADE approach categorizes the certainty of a body of evi-
dence as high, moderate, low, or very low. Randomized trials start
with high certainty of evidence; and this can be downgraded for
study limitations (i.e. risk of bias in included studies), inconsis-
tency in study results (i.e. presence of significant statistical hetero-
geneity), indirectness of the evidence, imprecision of intervention
effects (i.e. wide confidence intervals for the estimate of effects),or publication bias. The certainty of the evidence for cohort (and
other observational) studies, start as low, and can be upgraded if
there is a strong association; or a dose–response relationship; or
if all plausible confounding or bias would decrease the size of the
effect. In this review, we downgraded the certainty of the evidence
from randomized trials by one to two levels because of study lim-
itations and imprecision of the findings. We kept the certainty of
the evidence for the cohort study as low. Two authors conducted
data syntheses, with verification by a third author as required.
2.8. Reporting of the review
We have prepared this systematic review in line with guidance
on preferred reporting items for systematic reviews and meta-
analyses (PRISMA) [13]. The PRISMA statement contains items
deemed essential for non-biased reporting of systematic reviews,
including a four-phase flow diagram (Fig. 1).3. Results
3.1. Study selection
The literature search yielded 343 records; 29 from CENTRAL, 51
from PubMed, 261 from Scopus, and 2 from reference lists of
included studies [14,15]. Titles and abstracts of the papers were
screened and 321 clearly irrelevant articles were excluded
(Fig. 1). Full texts of the 22 remaining articles were assessed for eli-
gibility, and six papers met the inclusion criteria [14–19]. The char-
acteristics of the six included studies are shown in Table 1. Reasons
are provided for excluding the 16 publications [20–35] in Table 2.
3.2. Characteristics of included studies
The six included studies were conducted in the United States of
America (USA). These included three individually randomized tri-
als [14,16,17], two cluster randomized trials [18,19], and one
cohort study [15]. The studies enrolled a total number of 92,525
children, adolescents, and adults.
The included studies evaluated the impact of several interven-
tions versus a standard of care or no intervention on the rates of
MOVs and uptake of vaccines.
One individually randomized trial assessed the effects of provi-
der prompts with or without tracking by community health work-
ers [14]. A nurse screened the immunization histories of children
visiting primary care facilities, irrespective of the purpose of the
visit, and placed an MOV sticker on the charts of children in need
of vaccination; specifying the required vaccine doses. Another
study arm combined the provider prompts with tracking by com-
munity health workers. The latter identified under-vaccinated chil-
dren through medical charts and used postcards, telephone calls,
or home visits to recall them to their primary care providers to
receive the needed vaccines [14].
The second individually randomized trial assessed the effects of
a policy enforcing the screening and vaccination of all eligible chil-
dren during all visits to primary care providers; with removal of
legal guardian signature requirements [16]. Staff nurses screened
medical charts for vaccination status at all primary care visits
and, if a vaccination was due, attached a brightly colored vaccina-
tion reminder card to the front of the medical chart. Regarding the
elimination of legal guardian’s signature requirement, the legal
guardian signed one consent form before the receipt of any vacci-
nations; and succeeding vaccinations were given without the need
for additional consent [16].
The third second individually randomized trial used case man-
agement and parent education [17]. The case managers doing
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Fig. 1. Study selection process for this review.
Table 1
Study characteristics.
Study and year Site Study Design Participants Intervention Control Target vaccine
Rodewald 1999 [14] Rochester and
New York, USA
Randomized
trial
Infants from
0 to 12 months
Provider prompts and tracking using lay
health workers.
Standard of care DTP, influenza,
Hib
Minkovitz 2001 [15] Baltimore, USA Prospective
cohort
Children
3 years or
younger
Systematic verification of immunization
histories, and provision of chocolate bars
labeled, ‘‘Immunize On Time”
Standard of care DTP, hepatitis,
and influenza
Szilagyi 1996 [16] Monroe, USA Randomized
trial
Children aged
0 to 2 years
Screen and vaccinate at all visits; and
removing legal guardian signatures.
Standard of care DTP, OPV,
MMR, and Hib
Wood 1998 [17] Los Angeles and
California, USA
Randomized
trial
Infants Parent education and case management. No intervention Childhood
vaccines
Lin 2016 [18] Pittsburgh and
Houston, United
States of America
(USA)
Cluster
randomized trial
Adults Provider education and one on-one
coaching.
No intervention Influenza
Mayne 2014 [19] Philadelphia, USA Cluster
randomized trial
Adolescent
girls aged
11–17 years
Education, electronic prompts, & feedback. No intervention HPV
2924 A. Jaca et al. / Vaccine 36 (2018) 2921–2927home visits or following up with participants by telephone and
mail when immunization was due. The case managers also had
to educate or inform parents that it was safe to vaccinate the child
whether they had a cold, mild ear infection or any other mild dis-
eases [17].In the cohort study, a screening nurse produced computer print-
outs of vaccination records of each child at each acute care visit,
and attached the records to child’s encounter form. In addition,
during study visits, providers were given chocolate bars labeled,
‘‘Immunize On Time” [15].
Table 2
Characteristics of excluded studies.
Study Reason for exclusion
Holt (1995) [20] This is a cross-sectional study
Daley (2005) [21] This cohort study did not assess any intervention
Kuo (2004) [22] This is a cross-sectional study
McConnochie (1992)
[23]
This study did not assess any intervention
Stille (2004) [24] This is not a randomized trial or cohort study
Turner (2009) [25] This study did not assess any intervention
Skull (2007) [26] This study did not assess any intervention.
Verani (2007) [27] This cohort study did not assess any intervention
Sabnis (2003) [28] This is not a randomized trial or cohort study.
Allred (2011) [29] This study did not assess any intervention
Rao (2016) [30] This study did not assess any intervention
Dombkowski (2006)
[31]
This study did not assess any intervention
Kempe (2001) [32] This study did not assess any intervention
O’Leary (2014) [33] This study did not have missed opportunities as an
outcome
Shim (2005) [34] This study did not have missed opportunities as an
outcome
de Mattos (2003) [35] This is a cross-sectional study
A. Jaca et al. / Vaccine 36 (2018) 2921–2927 2925One of the cluster-randomized trials assessed the effects of a
multi-faceted intervention consisting of: convenient vaccination
services; communication with parents about the importance of
immunization and availability of vaccines; enhanced office sys-
tems to facilitate vaccination; and motivation through an office
vaccination champion [18].
Another study assessed the effects of combining clinician-
oriented and family-oriented interventions [19]. The clinician-
focused intervention consisted of three components, i.e., electronic
health record (EHR)-based vaccine awareness for any due vaccines,
a one hour educational presentation about the vaccine and three
quarterly performance feedback reports of captured immunization
opportunities at primary care visits. With regards to the family set-
ting, the interventions involved an outside vendor generated auto-
mated phone calls based on an EHR-generated roster. Participants
received reminder phone calls to notify them of any due vaccines,
they were also referred to an educational website and reminded
about upcoming preventive visits [19].
The studies reported outcome data on MOVs and vaccination
coverage for diphtheria-tetanus-pertussis (DTP) [14–16], hepatitis
B [15], influenza [14,15,18], Haemophilus influenzae type b (Hib)
[14,16], oral poliovirus (OPV) [16], measles-mumps-rubella
(MMR) [16], and human papillomavirus (HPV) [19] vaccines or
completion of childhood immunization schedule [17].3.3. Risk of bias in included studies
All trials had a high risk of bias due to lack of allocation conceal-
ment, lack of blinding of outcome assessors, and incomplete out-
come data (Table 3).Table 3
Risk of bias in included randomized trials.
Domain Lin 2016
Random sequence generation (selection bias)
Allocation concealment (selection bias)
Blinding of participants and personnel (Performance bias)
Blinding of outcome assessment (detection bias)
Incomplete outcome data (Attrition bias)
Selective reporting (Reporting bias)
Other biases
Low risk; High risk; Unclear risk.Furthermore, risk of bias was high in all the included studies
due to either inadequate, not reported or unclear methods of
sequence generation, allocation concealment and blinding for
some of the studies. The study by Lin et al. [18] did not report
how the allocation was generated while Wood et al. [17] did not
mention allocation generation at all. Mayne et al. [19], Rodewald
et et al. [14] and Szilagyi et al. [16] respectively used randomly per-
muted unequal blocks and two-by-two factorial design for allocat-
ing participants to the intervention or control groups. However,
none of the randomized trials reported any method of allocation
concealment. Concerning blinding, Lin et al. [18] and Wood et al.
[17] did not report it, whereas the study by Mayne et al. [19] did
not clearly state the exact method used. Rodewald et al. [14] and
Szilagyi et al. [16] stated that they blinded outcome assessors
and abstractors to study hypothesis and study group assignment
while they did not specify the method. The cohort study [15] had
high risk of bias because it scored yes for bias in measurement of
outcomes.
There was incomplete outcome data due to a loss of 654 out of
total number of 92,525 paticipants. This is due to some of the par-
ticipants dropping out of the study, incomplete medical informa-
tion, and provider records. Additionally, five of the included
studies mentioned several biases e.g. that some information was
not captured and inadequate provider record keeping.
None of the studies reported a protocol being available; hence it
was unclear whether selective reporting was a problem or not.3.4. Effects of interventions on the rates of missed opportunities for
vaccination and vaccination coverage
All studies reported effects of interventions on MOVs and vacci-
nation coverage. Given that MOVs are proxies for vaccination cov-
erage, we have emphasized the effects of on vaccination coverage;
rather both MOVs and vaccination coverage.
A study by Lin et al. [18] provided moderate certainty evidence
that communicating with patients about vaccines probably leads
to a reduction of missed opportunities for vaccination (RR 0.97,
95% CI 0.95–0.98) and an increase in vaccination coverage (RR
1.03, 95% CI 1.02–1.04). In addition, a study by Wood et al. [17]
showed low certainty of evidence that educating parents about
vaccines may lead to increased vaccination coverage (RR 1.92,
95% CI 1.38–2.68). Another study, by Mayne et al. [19], provided
low certainty evidence that education sessions concurrently tar-
geting clinicians and families may lead to increased vaccination
coverage (RR 1.25, 95% CI 1.08–1.46). A study by Szilagyi et al.
[16] provided low certainty evidence that lifting the requirement
to have a legal guardian’s signature before vaccination may have
little or no effect on vaccination coverage (RR 1.02, 95% CI 0.96–
1.09). Finally, a study by Rodewald et al. provided evidence of
low certainty that combining patient tracking and provider
prompts can substantially reduce missed opportunities and
increase vaccination coverage (RR 1.18, 95% CI 1.11–1.25) [14].Mayne 2014 Rodewald 1996 Szilagyi 1996 Wood 1998
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4.1. Summary of findings
This review included six studies and investigated the effective-
ness of different interventions aimed at decreasing missed oppor-
tunities for vaccination and increasing vaccination coverage. The
studies (five trials and one cohort study) were carried out in differ-
ent cities of the United States of America. The interventions
assessed included educational sessions, performance feedback,
outreach through postcards, phone calls and home visits, genera-
tion of printouts of each child’s vaccination record, changing prac-
tice guideline (i.e., vaccination without legal guardian’s signature),
communication with patients about the importance and availabil-
ity of vaccines, parent education and case management.
Regarding data reported on missed opportunities, it is evident
from the data provided by Lin et al. [18] that individuals who did
not receive the intervention, i.e., communication about the impor-
tance and availability of vaccines, had increased chances of missing
opportunities for vaccination. Furthermore, the data reported by
Rodewald et al. [14] show that individuals who received an inter-
vention were less likely to have missed opportunities for vaccina-
tion compared to people in the control group. The results from this
study also suggest that the interventions (such as patient tracking,
outreach, and provider prompting) are more effective in reducing
missed opportunities when they are used concurrently as opposed
to when they are used individually.
Although an ealier study by Sabnis et al. [28] did not compare
the rate of missed opportunities for vaccination between the inter-
vention and control groups, a decreased rate, following education
and feedback interventions was reported.
With regards to vaccination coverage, one study [19] using edu-
cation sessions as an intervention was more effective if it was tar-
geted at the family and clinician settings concurrently. It was also
apparent that there was a positive effect when tracking was com-
bined with prompting and outreach (postcards, phone calls and
home visits) [14]. Furthermore, results showed that educating par-
ents about the importance of vaccines was more effective in
increasing vaccination coverage than when they were not educated
[18]. Moreover, it was interesting to note that vaccinating children
without legal guardian’s signature was not effective in increasing
vaccination coverage [16].
Previous investigations also showed similar results, where indi-
viduals who received interventions such as provider education,
text messaging, mailed letters and telelphone reminders had
increased vaccination rates than those who did not [36–39]. In
concordance with Mayne et al. [19], Walling et al. [37] and Niccolai
et al. [39] also reported that interventions targeting recipients and
providers concurrently were effective in increasing vaccination
coverage than when they were used seperately.
4.2. Certainty of the evidence
The certainty of evidence was low to moderate. We down-
graded the certainty of the evidence to moderate or low due to
imprecision (wide confidence intervals) and high risk of bias.
4.3. Conclusions and implications for future research
The currently available evidence suggests the use of provider
education; patient education; and patient tracking, outreach, and
provider prompting as interventions to reduce missed opportuni-
ties for vaccination and improve vaccination coverage. Rigorous
studies are required to confirm these findings and increase thecertainty of the current evidence base. WHO is in the process of
generating evidence on interventions for reducing MOVs; there-
fore, there is a possibility of more data being published in the com-
ing years [40].
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Appendix A
Appendix 1: PubMed, Scopus, and Cochrane Library search
strategie.Search QueryPubMed
#1 (‘‘Immunization”[Mesh] OR‘‘Vaccination”[Mesh] OR
‘‘Immunization Programs”[Mesh] OR Immunization
OR immunization) AND (adhering OR adheren⁄ OR
uptake OR rate⁄ OR coverage)#2 ‘‘MISSED OPPORTUNITY” OR ‘‘MISSED
OPPORTUNITIES”#3 #1 AND #2
#4 (randomized controlled trial [pt] OR controlled
clinical trial [pt] OR randomized [tiab] OR placebo
[tiab] OR ‘‘clinical trials as topic”[mesh: noexp] OR
randomly [tiab] OR trial [tiab]) NOT (animals [mh]
NOT humans [mh])#5 ‘‘COHORT STUDY” OR ‘‘COHORT STUDIES”
#6 #3 AND (#4 OR #5Scopus
#1 ALL (((‘‘Immunization” OR ‘‘Vaccination” OR
‘‘Immunization Programs” OR Immunization OR
immunization) AND (adhering OR adheren⁄ OR
uptake OR rate⁄ OR coverage)) AND (‘‘MISSED
OPPORTUNITY” OR ‘‘MISSED OPPORTUNITIES”))#2 (ALL (((‘‘Immunization” OR ‘‘Vaccination” OR
‘‘Immunization Programs” OR Immunization OR
immunization) AND (adhering OR adheren⁄ OR
uptake OR rate⁄ OR coverage)) AND (‘‘MISSED
OPPORTUNITY” OR ‘‘MISSED OPPORTUNITIES”)))
AND (‘‘COHORT STUDY” OR ‘‘COHORT STUDIES”)#3 (ALL (((‘‘Immunization” OR ‘‘Vaccination” OR
‘‘Immunization Programs” OR Immunization OR
immunization) AND (adhering OR adheren⁄ OR
uptake OR rate⁄ OR coverage)) AND (‘‘MISSED
OPPORTUNITY” OR ‘‘MISSED OPPORTUNITIES”)))
AND (‘‘randomized controlled trial” OR ‘‘controlled
clinical trial” OR randomized OR placebo)#4 ((ALL (((‘‘Immunization” OR ‘‘Vaccination” OR
‘‘Immunization Programs” OR Immunization OR
immunization) AND (adhering OR adheren⁄ OR
uptake OR rate⁄ OR coverage)) AND (‘‘MISSED
OPPORTUNITY” OR ‘‘MISSED OPPORTUNITIES”)))
AND (‘‘COHORT STUDY” OR ‘‘COHORT STUDIES”))
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AND ((ALL (((‘‘Immunization” OR ‘‘Vaccination” OR
‘‘Immunization Programs” OR Immunization OR
immunization) AND (adhering OR adheren⁄ OR
uptake OR rate⁄ OR coverage)) AND (‘‘MISSED
OPPORTUNITY” OR ‘‘MISSED OPPORTUNITIES”)))
AND (‘‘randomized controlled trial” OR ‘‘controlled
clinical trial” OR randomized OR placebo))Cochrane Library
#1 ((‘‘Immunization” OR ‘‘Vaccination” OR
‘‘Immunization Programs” OR Immunization OR
immunization) AND (adhering OR adheren⁄ OR
uptake OR rate⁄ OR coverage)) AND (‘‘MISSED
OPPORTUNITY” OR ‘‘MISSED OPPORTUNITIES”)References
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